We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ultrasound Wound Debridement System Promotes Healing

By HospiMedica staff writers
Posted on 05 Mar 2008
An advanced low-frequency cavitational ultrasound offers a safe, cost-effective alternative to painful sharps debridement and other surgical modalities involved in wound care. More...


The Qoustic Wound Therapy System assists healing by gently removing dead or diseased tissue cells and bacteria, leaving healthy and pre-healing granulation tissue intact. It is also useful in preparing the wound bed for other therapies, such as grafts and flaps. The system employs a dome-shaped "Qurette,” which vibrates at 35 kHz, converting electrical energy to ultrasound waves and focusing them intensively on the wound. A sterile saline solution transfers the ultrasonic energy to the wound, where cavitation i.e., oscillation of microscopic bubbles that expand and collapse as they resonate with the ultrasound frequency, and acoustic microstreaming i.e., cellular-level fluid movement, separate dead and harmful cells from healthy tissue. As a result, dead and harmful cells are fragmented and destroyed, thus aiding in their easy removal with the edge of the Qurette.

The system is portable and can be used in various health care settings by wound care specialists, including physicians, registered nurses, nurse practitioners, physician assistants, physical therapists, and podiatrists. The system reduces splash and aerosolization. It can reduce wound care costs in several ways: fast setup, no required disposables, short procedure times, effective procedures that reduce debridement frequency, efficient use of saline, and fast cleanup. The Qoustic Wound Therapy System is a product of Arobella Medical (Minneapolis, MN, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"The Qoustic Wound Therapy System debrides by deploying focused ultrasound energy directly on the wound bed, notably improving the effectiveness of debridement versus sharps debridement alone. The use of ultrasound helps preserve healthy tissue and protects newly formed granulation tissue, while being gentle and efficient,” said Eliaz Babaev, Ph.D., president and CEO of Arobella Medical. "The system has the potential to significantly advance patient care and healthcare worker safety, as well as reduce costs.”

Low-frequency ultrasound debridement is emerging as a preferred method of care for many types of wounds, including pressure ulcers, diabetic ulcers, infected wounds, burns and other chronic wounds. Five to seven million people each year in the United States require treatment for chronic wounds resulting from ulcers, sores, burns, fistulas and other conditions. A significant number of the people with chronic wounds have diabetes, and rapid growth of the diabetic population is increasing the need for advanced wound care.


Related Links:
Arobella Medical

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.